Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.3%

2 terminated/withdrawn out of 15 trials

Success Rate

60.0%

-26.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 2
2(100.0%)
2Total
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT03849586Active Not Recruiting

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Role: lead

NCT04114266Completed

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD

Role: lead

NCT07545148Not Yet Recruiting

Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life

Role: lead

NCT07455097Active Not Recruiting

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

Role: collaborator

NCT02757274Active Not Recruiting

Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence

Role: lead

NCT06723574Completed

Sustainability in Urologic Practices

Role: collaborator

NCT06424275Enrolling By Invitation

Prostate Cancer Awareness and Initiative for Screening in the European Union

Role: lead

NCT04932902Enrolling By Invitation

ManAgement of pRiapiSm and Its Impact on Outcomes

Role: collaborator

NCT04294277Phase 2Terminated

Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery

Role: lead

NCT06866782Recruiting

European Registry of Next Generation Imaging in Advanced Prostate Cancer

Role: collaborator

NCT05479422Active Not Recruiting

Optilume Registry for Treatment of Stricture of the Anterior Urethra

Role: lead

NCT06772116Not Yet Recruiting

Focal Therapy in Localized Prostate Cancer: a Prospective Registry

Role: collaborator

NCT03665467Unknown

The Global Prevalence of Infections in Urology Study

Role: lead

NCT02380170Completed

Epidemiology and Outcomes of Gram Negative Urosepsis

Role: lead

NCT01435356Phase 2Terminated

Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy

Role: lead

All 15 trials loaded